Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical ...
Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for ...
A multilayered semiconductor acting as an optical sensor opens the way to miniaturized, adjunct spectrometers.
Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering.
Innovation is accelerating through bispecifics and dual payload strategies | Emerging ADC development approaches such as ...
Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics.
Sometimes, when an audio component dies, the root cause is something electrical. Sometimes, the issue ends up being ...
The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...
In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent ...
The waveLINE-003 trial demonstrates the efficacy of zilovertamab vedotin combined with standard therapy, with manageable safety profiles in difficult-to-treat DLBCL patients. ADCs provide logistical ...
Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.
Discover practical solutions and engineering insights for deploying 448G SerDes in AI and HPC cluster networks. In this white paper, you’ll learn: The impact of retimed vs. unretimed host ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback